Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population-Reference-Cited by-同舟云学术

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population

Published:2011-05-10 Issue:3 Volume:24 Page:537-546
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Johansson Per¹²,Mattsson Niklas³,Hansson Oskar⁴,Wallin Anders³,Johansson Jan-Ove²,Andreasson Ulf³,Zetterberg Henrik³,Blennow Kaj³,Svensson Johan²⁵

Affiliation:

1. Department of Neuropsychiatry, Skaraborg Hospital, Falköping, Sweden

2. Department of Endocrinology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

3. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden

4. Clinical Memory Research Unit, Clinical Sciences Malmö, Lund University, Lund, Sweden

5. Department of Endocrinology, Skaraborg Hospital, Skövde, Sweden

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood‐brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein‐β in patients with subcortical small‐vessel disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2022-01

2. Epigenetics of Alzheimer’s Disease;Biomolecules;2021-01-30

3. Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer’s Disease;Journal of Alzheimer's Disease;2021-01-19

4. Growth Hormone and Neuronal Hemoglobin in the Brain—Roles in Neuroprotection and Neurodegenerative Diseases;Frontiers in Endocrinology;2021-01-08

5. Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2021-01